Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management
Movement Disorders Clinical Practice · 23.09.2026
DOI: 10.1002/mdc3.70836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 23.09.2026. Verfasst von Galit Kleiner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Austin Centre for Neurology and Behavioral Supports, Baycrest Health Sciences, Toronto, ON, Canada. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Paratonia is an involuntary and variable resistance to passive movement that emerges with cognitive decline in dementias of different etiologies, with prevalence approaching 90% to 100% in end‐stage disease. It is common in Parkinson disease and the atypical parkinsonisms. The involuntary resistance is frequently interpreted as volitional refusal of care and may be managed with psychotropic medication. We propose that paratonia meets the criterion by which a movement disorder is defined, with a reproducible and distinct clinical phenomenology that is operationalized in a validated bedside instrument and is distinguishable from parkinsonian rigidity, spasticity, and dystonia. We present a preliminary staging schematic in which treatment with botulinum toxin A (BoNT‐A) is indicated when the posturing interferes with care and the contraction remains dynamic, before fixed contracture. Preliminary evidence from a randomized pilot trial and observational studies supports BoNT‐A for care‐interfering paratonia. Classification of paratonia as a movement disorder would enable a dedicated research, education and advocacy platform to advance clinical care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Austin Centre for Neurology and Behavioral Supports, Baycrest Health Sciences, Toronto, ON, Canada.
- Katz Interprofessional Research Program in Geriatric Dementia Care, Rotman Research Institute, Toronto, ON, Canada.
- Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
- Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
- Edmond J. Safra Program in Parkinson's Disease and Rossy PSP Centre, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
- Krembil Brain Institute, Toronto, ON, Canada.
ORCID-Profile: Galit Kleiner, Christos Ganos, Anthony E Lang
Zitieren
APA
Kleiner, G., Ganos, C., & Lang, A. E. (2026). Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70836
Vancouver
Kleiner G, Ganos C, Lang AE. Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70836
BibTeX
@article{Kleiner2026,
author = {Kleiner, Galit and Ganos, Christos and Lang, Anthony E},
title = {Should Paratonia Be Considered a Movement Disorder? Implications for Clinical Management},
journal = {Movement Disorders Clinical Practice},
year = {2026},
doi = {10.1002/mdc3.70836}
}
EUVIMED